Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -14.85%42.11M | -26.76%89.32M | -26.77%49.45M | 6.08%121.95M | 13.21%67.52M | -9.49%114.96M | -15.50%59.64M | 6.53%127.01M | 13.86%70.58M | -31.81%119.22M |
| Operating income | -14.85%42.11M | -26.76%89.32M | -26.77%49.45M | 6.08%121.95M | 13.21%67.52M | -9.49%114.96M | -15.50%59.64M | 6.53%127.01M | 13.86%70.58M | -31.81%119.22M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Administrative expenses | -9.47%-16.04M | -4.51%-29.03M | -12.03%-14.65M | -7.64%-27.78M | 3.43%-13.08M | 2.27%-25.81M | 2.98%-13.54M | -0.29%-26.41M | -8.75%-13.96M | 2.71%-26.33M |
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | --500K | ---- | ---- | ---- |
| Revaluation surplus | ---- | -22.67%37.18M | ---- | -35.81%48.08M | ---- | 256.67%74.9M | ---- | 151.34%21M | ---- | 7.05%-40.9M |
| -Changes in the fair value of investment property | ---- | -22.67%37.18M | ---- | -35.81%48.08M | ---- | 256.67%74.9M | ---- | 151.34%21M | ---- | 7.05%-40.9M |
| Impairment and provision | 3,891.40%3.53M | 52.11%-16.93M | -101.06%-93K | 25.98%-35.36M | 109,637.50%8.78M | -185.27%-47.77M | -86.89%8K | -27.08%-16.74M | 190.48%61K | ---13.18M |
| -Other impairment is provision | 3,891.40%3.53M | 52.11%-16.93M | -101.06%-93K | 25.98%-35.36M | 109,637.50%8.78M | -185.27%-47.77M | -86.89%8K | -27.08%-16.74M | 190.48%61K | ---13.18M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -26.55%-2.45M | 41.88%-3.7M | 51.76%-1.94M | 32.05%-6.36M |
| Special items of operating profit | 51.11%68K | 238.92%1.19M | -82.14%45K | -80.49%352K | -71.62%252K | 232.84%1.8M | 221.74%888K | -77.48%542K | -71.16%276K | 107.79%2.41M |
| Operating profit | -14.65%29.66M | -23.79%81.73M | -45.26%34.75M | -9.18%107.25M | 40.91%63.47M | 16.11%118.09M | -18.14%45.04M | 191.73%101.71M | 19.31%55.02M | -46.35%34.86M |
| Financing cost | 51.04%-1.66M | -20.93%-6.48M | -32.91%-3.38M | 19.71%-5.36M | ---2.54M | ---6.67M | ---- | ---- | ---- | ---- |
| Share of profits of associates | -0.96%-841K | 55.16%-4.1M | 71.68%-833K | -111.83%-9.13M | -106.39%-2.94M | -1.34%-4.31M | -39.98%-1.43M | -118.92%-4.26M | -14.51%-1.02M | 930.97%22.49M |
| Earning before tax | -11.04%27.16M | -23.29%71.15M | -47.34%30.53M | -13.40%92.75M | 32.94%57.99M | 9.91%107.11M | -19.23%43.62M | 69.92%97.45M | 19.40%54.01M | -7.91%57.35M |
| Tax | 35.31%-1.65M | 80.01%-1.41M | 47.14%-2.55M | -2.55%-7.05M | 3.87%-4.82M | 34.30%-6.87M | 26.17%-5.02M | 6.31%-10.46M | -13.04%-6.79M | 29.68%-11.16M |
| After-tax profit from continuing operations | -8.83%25.51M | -18.63%69.75M | -47.36%27.99M | -14.49%85.71M | 37.72%53.17M | 15.22%100.24M | -18.23%38.6M | 88.35%86.99M | 20.38%47.21M | -0.46%46.19M |
| Earning after tax | -8.83%25.51M | -18.63%69.75M | -47.36%27.99M | -14.49%85.71M | 37.72%53.17M | 15.22%100.24M | -18.23%38.6M | 88.35%86.99M | 20.38%47.21M | -0.46%46.19M |
| Minority profit | -16.67%-7K | 1,390.91%284K | -20.00%-6K | 70.27%-22K | -103.47%-5K | -72.09%-74K | 726.09%144K | -10.26%-43K | -130.00%-23K | 97.08%-39K |
| Profit attributable to shareholders | -8.83%25.52M | -18.98%69.46M | -47.36%27.99M | -14.53%85.73M | 38.25%53.17M | 15.25%100.31M | -18.58%38.46M | 88.28%87.04M | 20.41%47.23M | -3.17%46.23M |
| Dividend | ---- | -25.00%40.24M | ---- | 0.00%53.65M | ---- | 0.00%53.65M | ---- | 100.00%53.65M | ---- | 0.00%26.82M |
| Basic earnings per share | -8.65%0.0095 | -19.06%0.0259 | -47.47%0.0104 | -13.51%0.032 | 38.46%0.0198 | 15.63%0.037 | -18.75%0.0143 | 88.24%0.032 | 20.55%0.0176 | -5.56%0.017 |
| Diluted earnings per share | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.